# Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery

> **NCT01892930** · NA · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 15 (actual)

## Conditions studied

- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer

## Interventions

- **RADIATION:** stereotactic body radiation therapy
- **PROCEDURE:** therapeutic conventional surgery
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01892930
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-11
- **Primary completion:** 2015-12-30
- **Final completion:** 2016-12-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01892930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01892930, "Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01892930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*